The incidence of Bmi‐1 positivity is augmented in grades II‐IV in human gliomas, and Bmi‐1‐positive cells frequently hold clinical importance in prognostic evaluations of overall survival in patients with glioma [31, 32, 33]. The gene discussed is BMI1; the disease is central nervous system cancer.